Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00490 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Thordur Hendrickson-Rebizant und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical analysis Laboratory, College of Pharmacy, University of Manitoba, 750 McDermot Avenue West, Winnipeg, Manitoba R3E 0T5, Canada. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Enzyme Inhibitors, Peptides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, CancerCare Manitoba Foundation, University of Manitoba.
Abstract (Originalsprache)
Protein arginine N-methyltransferases (PRMT) are a family of S-adenosyl-l-methionine (SAM)-dependent enzymes that transfer methyl-groups to the ω-N of arginyl residues in proteins. PRMTs are involved in regulating gene expression, RNA splicing, and other activities. PRMT1 is responsible for most cellular arginine methylation, and its dysregulation is involved in many cancers. Accordingly, many groups have targeted PRMT1 using small molecules and peptide inhibitors. In this Perspective, we discuss the structure and function of selected peptide and small molecule inhibitors of PRMT1. We examine inhibitors that target the substrate arginyl peptide, SAM, or both binding sites, and the type of inhibition that results. Small molecules, and peptides that are bisubstrate, and/or PRMT transition state mimic inhibitors as well as inhibitors that alkylate PRMTs will be discussed. We define a structure-activity relationship for the aromatic/heteroaromatic N-methylethylenediamine inhibitors of PRMT1 and review current progress of PRMT1 inhibitors in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmaceutical analysis Laboratory, College of Pharmacy, University of Manitoba, 750 McDermot Avenue West, Winnipeg, Manitoba R3E 0T5, Canada.
- Paul Albrechtsen Research Institute, CancerCare Manitoba, Winnipeg, MB R3E 0 V9, Canada.
- Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
- Faculty of Pharmaceutical Sciences, The University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada.
ORCID-Profile: Thordur Hendrickson-Rebizant, Sadhana R N Sudhakar, Michael J Rowley, James R Davie, Ted M Lakowski
Förderung
- Canadian Institutes of Health Research
- CancerCare Manitoba Foundation
- University of Manitoba
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Hendrickson-Rebizant, T., Sudhakar, S. R. N., Rowley, M. J., Frankel, A., Davie, J. R., & Lakowski, T. M. (2024). Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00490
Vancouver
Hendrickson-Rebizant T, Sudhakar SRN, Rowley MJ, Frankel A, Davie JR, Lakowski TM. Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00490
BibTeX
@article{HendricksonRebizant2024,
author = {Hendrickson-Rebizant, Thordur and Sudhakar, Sadhana R N and Rowley, Michael J and Frankel, Adam and Davie, James R and Lakowski, Ted M},
title = {Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00490}
}
EUVIMED